Complete Conference Management 31st Annual San Diego Heart Failure Summer Symposium 2025
Introduction
The Complete Conference Management 31st Annual San Diego Heart Failure Summer Symposium 2025 is a comprehensive cardiovascular education program dedicated to the latest advances in heart failure diagnosis, prevention, and treatment. This expert-led symposium delivers practical, evidence-based guidance on modern heart failure management, integrating emerging pharmacologic therapies, device-based interventions, catheter-based procedures, and multidisciplinary care strategies.
Designed for clinicians managing patients across the full spectrum of heart failure, the symposium combines didactic lectures, case-based discussions, interactive Q&A sessions, and real-world clinical implementation strategies to improve patient outcomes and optimize contemporary heart failure care.
The curriculum integrates:
- Heart failure management
- HFpEF treatment
- Cardiorenal syndrome
- Cardiac amyloidosis
- Pulmonary arterial hypertension
- Advanced heart failure
- Cardiac transplantation
- Atrial fibrillation in heart failure
- Catheter-based interventions
- Genetics and gene therapy
into a modern, evidence-based cardiovascular educational experience.
Course Overview
📚 Program: Complete Conference Management 31st Annual San Diego Heart Failure Summer Symposium 2025
📅 Course Year: 2025
🎥 Included Content
- 34 video lectures
- 41 PDF presentations
💾 Course Size: 12.54 GB
🏨 Location
Hilton La Jolla Torrey Pines, San Diego, California
🎓 Educational Format
- Didactic presentations
- Interactive case discussions
- Q&A sessions
- Clinical management vignettes
- Hybrid live and online learning
The symposium provides practical cardiovascular education focused on integrating emerging heart failure therapies into clinical practice.
Educational Focus
The program focuses on:
- Contemporary heart failure management
- HFpEF treatment advances
- Cardiorenal-metabolic syndrome
- Advanced heart failure therapies
- Cardiac amyloidosis
- Pulmonary hypertension
- Hypertrophic cardiomyopathy
- Cardiac transplantation
- Device-based heart failure therapy
- Catheter-based cardiovascular interventions
The curriculum emphasizes practical implementation of current evidence and guideline-directed therapy in heart failure care.
Learning Objectives
After completing this activity, learners strengthen their ability to:
- Summarize current and emerging therapies for heart failure prevention and treatment
- Select appropriate medical and device-based therapies for individual heart failure patients
- Apply evidence-based strategies to improve heart failure outcomes
- Implement practical approaches for HFpEF, pulmonary hypertension, and cardiac amyloidosis management
- Integrate catheter-based and advanced heart failure interventions into patient care
- Recognize population-specific responses to heart failure therapies in women, minorities, and elderly patients
- Utilize modern approaches to atrial fibrillation management and sudden cardiac death prevention in heart failure
- Apply multidisciplinary strategies for advanced heart failure and cardiogenic shock management
The educational material combines guideline-focused review with practical clinical application and multidisciplinary cardiovascular care.
Advances in Heart Failure Management
A major component of the symposium focuses on contemporary treatment strategies for heart failure.
Covered Areas
- Guideline-directed medical therapy (GDMT)
- Emerging pharmacologic treatments
- HFpEF management advances
- Heart failure prevention strategies
- Advanced heart failure interventions
- Personalized treatment approaches
The curriculum reviews state-of-the-art approaches for optimizing outcomes in heart failure patients.
Cardiorenal-Liver-Metabolic Axis
Dedicated sessions explore the expanding understanding of interconnected cardiovascular and metabolic disease.
Topics Include
- Cardiorenal syndrome
- Cardiometabolic disease
- Liver dysfunction in heart failure
- Metabolic therapies
- SGLT2 inhibitor applications
- Multisystem heart failure management
Participants strengthen understanding of integrated organ-system interactions in cardiovascular disease.
Amyloidosis, PAH & Hypertrophic Cardiomyopathy
The educational content includes specialized review of complex cardiovascular disorders.
Educational Topics
- Cardiac amyloidosis diagnosis and treatment
- Pulmonary arterial hypertension (PAH)
- Hypertrophic cardiomyopathy management
- Infiltrative heart disease
- Advanced imaging and diagnostics
- Emerging therapeutic strategies
The sessions emphasize evidence-based evaluation and management of challenging heart failure syndromes.
Arrhythmias & Sudden Cardiac Death Prevention
Specialized educational sessions address rhythm management in heart failure populations.
Covered Areas
- Atrial fibrillation management
- Sudden cardiac death prevention
- Electrophysiologic interventions
- Device-based arrhythmia therapy
- ICD and CRT strategies
- Genetics and gene therapy
The curriculum highlights practical arrhythmia management and prevention strategies in advanced cardiovascular care.
Advanced Heart Failure & Shock
A central educational focus involves advanced heart failure therapies and critical care management.
Topics Include
- Cardiogenic shock management
- Mechanical circulatory support
- Advanced heart failure pathways
- Cardiac transplantation updates
- Catheter-based interventions
- End-stage heart failure care
Participants gain practical skills for managing critically ill heart failure patients.
Interactive Clinical Learning
The symposium incorporates practical and interactive educational experiences.
Included Features
- Morning clinical case vignettes
- Expert faculty discussions
- Interactive Q&A sessions
- Real-world management strategies
- Multidisciplinary perspectives
- Practical treatment implementation guidance
The interactive format strengthens clinically applicable cardiovascular decision-making.
Featured Symposium Highlights
Special educational highlights include:
- 11th Annual Stanley Lloyd, M.D. Lecture
- “Improving the Quality of Care and Outcomes for Heart Failure”
- 2nd Annual Founders Lecture
- “Heart Failure – Looking Back and Looking Forward: A 100 Year Perspective”
- Featured sessions on cardiac transplant and cardiometabolic disease
These presentations provide historical context, future perspectives, and advanced clinical insight into evolving heart failure management.
Educational Experience
The course combines:
- Advanced heart failure education
- HFpEF management
- Cardiorenal syndrome review
- Pulmonary hypertension updates
- Cardiac amyloidosis education
- Arrhythmia management
- Advanced cardiovascular therapeutics
- Multidisciplinary heart failure care
The educational structure emphasizes evidence-based cardiovascular medicine and practical implementation of modern heart failure therapies.
Why This Course Stands Out
Comprehensive Heart Failure Education
Covers prevention, diagnosis, pharmacologic therapy, device interventions, and advanced heart failure management.
Strong Multidisciplinary Focus
Integrates cardiology, electrophysiology, transplant medicine, metabolic disease, and critical care perspectives.
Emphasis on Emerging Therapies
Highlights the latest advances in HFpEF, amyloidosis, genetics, and catheter-based interventions.
Interactive Case-Based Learning
Combines expert lectures with practical clinical case discussions and management strategies.
Hybrid Educational Access
Offers both live participation and extended online access for flexible learning.
Clinical Value
The Complete Conference Management 31st Annual San Diego Heart Failure Summer Symposium 2025 delivers advanced cardiovascular education through integrated coverage of:
- Heart failure management
- HFpEF therapy
- Cardiorenal-metabolic disease
- Pulmonary hypertension
- Cardiac amyloidosis
- Hypertrophic cardiomyopathy
- Arrhythmia management
- Advanced heart failure
- Cardiac transplantation
- Catheter-based cardiovascular interventions
- Genetics and gene therapy
- Evidence-based cardiovascular medicine
The combination of expert-led instruction, multidisciplinary perspectives, practical case discussions, and emerging cardiovascular therapies makes this symposium highly valuable for clinicians seeking advanced education in contemporary heart failure management.
Topics:
Friday, June 27, 2025 Pacific Time
- 7:00am Registration/Coffee/Visit Exhibits
- 7:30-8:10 Coffee and Case Vignettes Drs. Greenberg, Bhatia, Narezkina and Wilkinson
- 8:20-9:20 PRODUCT THEATRE I – Breakfast Session – Non-CME A Near-Complete TTR Stabilizer Intentionally Designed for Patients With ATTR-CM Speaker: Marcus Anthony (Tony) Urey, MD Sponsored by: BridgeBio
- 9:20 Visit Exhibits
- 9:30 Welcome and Introduction to the 31st Annual San Diego Summer Heart Failure Symposium Barry Greenberg, MD
- SESSION I – The Cardiorenal Liver Metabolic Axis Pam Taub, MD (Moderator)
- 9:40-10:00 FEATURED LECTURE I The Cardiometabolic-Kidney-Liver Syndrome Pam Taub, MD, FACC
- 10:00-10:20 GLP-1 Agonists for Treating Obesity and CV Disease Harpreet Bhatia, MD
- 10:20-10:40 Novel Approaches for Optimizing Therapy of Dyslipidemia to Reduce CV Risk Michael Wilkinson, MD
- 10:40-11:00 Reducing the Risk of Cardiovascular-Kidney Disease with Finerenone Barry Greenberg, MD
- 11:00-11:20 Cardiometabolic Disease in Transplant Patients Antoinette Birs, MD
- 11:20-11:40 Identifying and Treating Chemotherapy Induced Cardiac Disease Anya Narezkina, MD
- 11:40-12:00 Update on Treating Patients with Aortic Stenosis Gary Ma, MD
- 12:00-12:20 Audience Q/A Pam Taub, MD (Moderator) Drs. Bhatia, Wilkinson, Greenberg, Birs, Narezkina, Ma and Andrew Willeford, PharmD (Panelists)
- 12:20 Visit Exhibits
- 12:30-1:30 PRODUCT THEATRE II – Lunch Session – Non-CME Introduction to AMVUTTRA® (vutrisiran) Rola Khedraki, MD Supported by: Alnylam
- 1:30 Visit Exhibits
- Session II – Advances in Treating HFpEF, PAH and Amyloidosis Marcus Anthony (Tony) Urey, MD (Moderator)
- 1:45-2:05 Advances in Managing Patients with HFpEF Hilary Shapiro, MD
- 2:05-2:25 Defining and Treatment Pulmonary Arterial Hypertension (PAH) in 2025: What’s the Best Approach? Nick H. Kim, MD
- 2:25-2:45 Diagnosing and Treating Amyloidosis: How Do the Experts Do It? Marcus Anthony (Tony) Urey, MD
- 2:45 Coffee Break/Visit Exhibits
- Session III – Hypertrophic Cardiomyopathy Jorge Silva Enciso, MD (Moderator)
- 3:00-3:20 Imaging the Heart to Identify Patients with HCM and Define Risk of Future Events Albert Hsaio, MD
- 3:20-3:40 Myosin Inhibitors and Other Novel Approaches for Treating Hypertrophic Cardiomyopathy Jorge Silva Enciso, MD
- 3:40-4:00 Gene Therapy for HCM Barry Greenberg, MD
- 4:00-4:15 Patient Perspective HCM Patient – TBD
- 4:15-4:45 Case Presentation/Audience Participation Tony Urey (Moderator) Drs. Shapiro, Silva Enciso, Hsaio, Greenberg, TBD (Panelists)
- 4:45 Adjourn Day 1
Saturday, June 28
- 7:00am Registration Opens
- 7:30-8:10 Coffee and Case Vignettes Drs. Greenberg, Wettersten, Elkayam, Heywood
- 8:20-9:20 PRODUCT THEATRE III – Breakfast Session – Non-CME Rethinking Hyperkalemia Management in Patients on RAASi Therapy Speakers: Vicky Kuo, PharmD, BCTXP and Vladimir Yurukov, PharmD, BCPS, APh Sponsored by: AstraZeneca
- 9:30 Welcome and Introduction to the 31st Annual San Diego Summer Heart Failure Symposium – Day 2 Barry Greenberg, MD
- Session IV – Managing Patients with Heart Failure Barry Greenberg, MD (Moderator)
- 9:40-10:10 11th Annual Stanley Lloyd, MD Lecture Improving the Quality of Care and Outcomes for Heart Failure Gregg Fonarow, MD
- 10:10-10:30 Managing Social Determinants That Predispose Patients to Heart Failure Cheryl Anderson, PhD
- 10:30-10:45 Selecting Additional Guideline Recommended Therapies That Improve Outcomes Uri Elkayam, MD
- 10:45-11:00 Remote Monitoring Using Wearable and Implantable Devices J Thomas Heywood, MD, FACC
- 11:00-11:15 New Diuretic Options for Managing Volume Overload Nicholas Wettersten, MD
- 11:15-11:30 Cardiac Contractility Modulation Farshad Raissi, MD
- 11:30-11:45 Living with Heart Failure: A Patient’s Perspective Rhonda Monroe
- 11:45-12:10 Case Presentation and Panel Discussion with Audience Participation Antoinette Birs, MD (Presenter) Drs Fonarow, Anderson, Heywood, Elkayam, Wettersten, Raissi and Rhonda Monroe (Panelists)
- 12:10 Visit Exhibits
- 12:20-1:20 PRODUCT THEATRE IV – Lunch Session – Non-CME hATTR Progression: Addressing Polyneuropathy Rajeev Mohan, MD Supported by: AstraZeneca
- 1:20-1:45 FOUNDERS LECTURE Heart Failure – Looking Back and Looking Forward: A 100 year Perspective Clyde Yancy, MD
- Session V – Atrial Fibrillation/Preventing Sudden Cardiac Death/Genetics and Gene Therapy Kimberly Hong, MD (Moderator)
- 1:45-2:00 Atrial Fibrillation: Rhythm vs Rate Control? Anticoagulation vs LAA Occlusion? Jonathan Hsu, MD
- 2:00-2:15 Preventing Sudden Cardiac Death; Role of Wearable Devices and New ICDs Fred Han, MD
- 2:15-2:30 Evaluating and Counseling Patients (and Their Families) with Suspected Genetic Cardiomyopathy Kimberly Hong, MD
- 2:30-2:45 Advances in Gene Therapy for Patients with Cardiomyopathy Barry Greenberg, MD
- 2:45-2:55 Gene Therapy – A Patients’s Perspective Deborah Hoffmann and Barry Greenberg, MD
- 2:55 Coffee Break/Visit Exhibits
- Session VI – Catheter Based Interventions, Shock and Management of Advanced Heart Failure Hao (Howie) Tran, MD (Moderator)
- 3:10-3:25 Catheter Based Interventions for Mitral and Tricuspid Valve Disease Ryan Reeves, MD
- 3:25-3:40 Recognition and Treatment of Cardiogenic Shock Hao (Howie) Tran, MD
- 3:40-3:55 Use of Percutaneous Support Devices to Treat Patients with Shock Rola Khedraki, MD
- 3:55-4:10 FEATURED LECTURE II What’s New in Cardiac Transplant Marcus Anthony (Tony) Urey, MD
- 4:10-4:25 Improving Outcomes with LVADs Mark Kearns, MD
- 4:25-4:40 Heart Transplant: A Patient Perspective Speaker TBD
- 4:40-5:00 Panel Discussion Dr Howie Tran (Moderator) Drs. Yancy, Hong, Greenberg, Urey, Khedraki, Kearns, Meghan Philbrick PA, Jade Kozach PharmD (Panelists)








